Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01712555
Other study ID # New York Eye and Ear Infirmary
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2011
Est. completion date December 15, 2017

Study information

Verified date August 2018
Source Fox, Donald Munro, M.D., P.C.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various gels (Restylane, Radiesse) are temporary had have their own disadvantages. This study seeks to demonstrate an improvement in the retention of injected autologous fat by mixing in autologous PRP (platelet rich plasma).


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date December 15, 2017
Est. primary completion date December 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria: anophthalmos, orbital atrophy -

Exclusion Criteria:poor anesthesia risk, people outside a 100 mile radius of New York City

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
autologous fat grafting with PRP to anophthalmic orbits


Locations

Country Name City State
United States New York Eye and Ear Infirmary New York New York

Sponsors (1)

Lead Sponsor Collaborator
Fox, Donald Munro, M.D., P.C.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improved retention of autologous fat injected into anophthalmic sockets Non contrast MRIs of the orbits are obtained before, immediately after, and one year after injection of autologous fat mixed with autologous PRP (platelet rich plasma) 1-5 yrs
See also
  Status Clinical Trial Phase
Completed NCT02244671 - Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma) N/A

External Links